
August Troendle
$2.58B
as of 04/02/25
About August Troendle
August Troendle is the CEO of Medpace, a clinical research company he founded in Cincinnati, Ohio in 1992; he owns about 19% of the stock.
Medpace conducts clinical trials for pharmaceutical companies seeking to bring drugs, vaccines or medical devices to market.
Before starting Medpace, Troendle spent five years as a director at Swiss pharma company Sandoz, now known as Novartis.
He also briefly worked as a medical review officer at the FDA's division of metabolic and endocrine drug products from 1986 to 1987.
A doctor with an M.D. from the University of Maryland, Troendle has also served on the boards of several public and private healthcare companies.
Personal stats
Citizenship
United States of AmericaSource of wealth
Pharmaceutical servicesResidence
Cincinnati, OhioBirth date
01/01/56 (age 69)Education
Medical Doctor, University of MarylandSelf-made
self-madeAugust Troendle’s fortune is worth

43K
troy ounces of gold

40K
median U.S. household

26K
median U.S. income

0.052%
U.S. credit card volume

0.01%
GDP of the United States

0.008%
United States debt
Net worth history
Annual ranking
Net worth over time
Real-time ranking
Financial assets
NASDAQ | MEDP-US
MedpaceNASDAQ | MEDP-US
MedpaceNASDAQ | MEDP-US
MedpaceNASDAQ | MEDP-US
MedpaceNASDAQ | MEDP-US
MedpaceNASDAQ | MEDP-US
MedpaceNASDAQ | MEDP-US
MedpaceImages © Forbes.com. All rights reserved.